1548 — Genscript Biotech Share News
0.000.00%
Last trade - 00:00- HK$76.05bn
- HK$72.43bn
- $959.53m
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale
Brief: Genscript Biotech To Place 77.1 Million Shares At HK$30.50 Per Share
Genscript Biotech drops most in 17 months on unit spinoff proposal
Brief: Genscript Biotech Proposes Spin-Off And Separate Listing Of Probio Technology
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
Chinese vaccine makers jump on news of key success in cancer treatment
Chinese vaccine makers jump on news of key success in cancer treatment, CanSino leads
China's GenScript Biotech H1 revenue rises on AI drug discovery
Brief: Genscript Biotech Says H1 Adjusted Net Profit Up 203.3% Y/Y
Legend Biotech slides on $226 mln share sale
Genscript hits 4-week high on associate's promising blood cancer cell therapy
Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales
Brief: Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth
Brief: Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth
Brief: Genscript Biotech Expects FY2025 Adjusted Net Profit Of US$207.3 Million-US$241.9 Million
US lawmakers urge Pentagon to add DeepSeek, Xiaomi to list of firms allegedly aiding Chinese military (updated)